401
Participants
Start Date
September 30, 2004
Primary Completion Date
May 31, 2006
Study Completion Date
October 31, 2010
ZoMaxx™ Drug-Eluting Coronary Stent System
Drug eluting stent implantation stent in the treatment of coronary artery disease.
TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent System
Drug eluting stent implantation stent in the treatment of coronary artery disease.
La Tour Hospital, Meyrin-Geneva
Middelheim Algemeen Ziekenhuis, Antwerp
KU Leuven - UZ Gasthuisberg, Leuven
St. Vincent's Hospital, Fitzroy
Monash Medical Center, Victoria
C.H.U. Sart Tilman, Liège
University Hospital Zürich, Zurich
Herzzentrum Bodensee, Kreuzlingen
Onze Lieve Vrouw Hospital, Aalst
Universitätsklinikum Eppendorf, Hamburg
Hôpital de Rangueil - CHU, Toulouse
Clinique Pasteur, Toulouse
Clinique Saint Gatien, Tours
St.Johannes Krankenhaus, Dortmund
Universitätsklinikum Essen, Essen
Herzzentrum Siegburg GmbH, Siegburg
Herzzentrum Bad Krozingen, Bad Krozingen
Cardiology Practice and Hospital Prof. Silber, Munich
Polyclinique les Fleurs, Ollioules
Centre Cardilogique du Nord, 32-36, rue des Moulins Gémeaux, Saint-Denis
Skejby Sygehus, Aarhus
Rigshospitalet / University of Copenhagen, Copenhagen
Herzzentrum Leipzig, Leipzig
Erasmus Medical Center, Rotterdam
Auckland City Hospital, Auckland
Dunedin Hospital, Dunedin
Hospital de Santa Cruz, Carnaxide
Barts and the London NHS Trust, London
Royal Brompton Hospital, London
Lead Sponsor
Abbott Medical Devices
INDUSTRY